Bankruptcy Judge Greenlights Final $46.75 Million Payout for 23andMe Data Breach Victims
A U.S. bankruptcy judge has officially approved a final $46.75 million class-action settlement for victims of the massive 2023 23andMe data breach. The decision provides a definitive resolution to a prolonged legal battle. The breach initially compromised the highly sensitive genetic profiles and personal information of roughly 6.9 million customers.
Because 23andMe filed for Chapter 11 bankruptcy protection and restructured its corporate identity as Chrome Holding Co., the payout mechanics had to be finalized through
sfrcollege.org federal bankruptcy court. The court ruled that the agreement was fair and served the best interests of the trust established to liquidate the former DNA-testing giant’s remaining liabilities.
Anatomy of the $46.75 Million Fund
The cash settlement operates under a strict, court-approved framework designed to reconcile consumer losses while prioritizing the remaining stakeholder assets.
The court’s final order recognizes that $14.29 million has already been distributed to affected consumers during the preliminary stages of the litigation. Consequently, the newly approved deal authorizes the bankruptcy administrator to distribute the remaining $32.46 million balance to valid claimants.
The exact payouts for individual United States class members vary sharply depending on the severity of their documentation and the nature of the data compromised:
Extraordinary Claims: Impacted users who suffered severe, documented out-of-pocket financial losses or extreme identity theft hardships are eligible for tier-one cash compensation of up to $10,000.
Health Information Claims: Class members whose sensitive health-related genetic markers or diagnostic details were explicitly scraped can claim up to $165.
Statutory Cash Claims: Standard valid U.S. consumer submissions will receive a flat pro-rata distribution estimated at around $100.
Non-Cash Security Benefits: Regardless of upfront cash tiers, all validated class members are entitled to 5 years of premium enrollment in the Privacy & Medical Shield + Genetic Monitoring program.
Deadlines and Next Steps for Claimants
For individuals wondering about their current standing or expecting an immediate check, the legal windows for entering the settlement pool have formally closed.
U.S. Consumer Windows: The absolute deadline to submit a primary U.S. claim form passed on February 17, 2026. Class members who received notice of incomplete or deficient forms had until June 12, 2026, to submit a cure form.
Canadian Consumer Window: A separate, parallel cross-border settlement pool was established for affected Canadian residents. That distinct claims portal officially concluded its intake on June 25, 2026.
The Waiting Period: The court emphasized that checks will not be mailed immediately. Because 23andMe’s assets are tied up in a broader, complex multi-million dollar Chapter 11 bankruptcy reconciliation, the true timeline for checks arriving in mailboxes or bank accounts will take several months or longer. Class members can monitor status updates via the official 23andMe data settlement administration program.
From Market Darling to Bankruptcy Protection
The approval of this payout marks the final chapter of a dramatic corporate downfall. Founded in 2006, 23andMe rode the wave of the direct-to-consumer genetic testing boom, eventually going public in 2021 with a peak market valuation of $6 billion. However, the company struggled to monetize its data and never generated an annual profit.
